格隆汇2月26日｜A股代糖概念股短线拉升，其中，保龄宝封涨停板，三元生物、金禾实业、华康股份 等跟涨。 ...

北京市东城区建国门内大街 26 号新闻大厦 7 层、8 层 电话：010-88004488/66090088 传真：010-66090016 邮编：100005 北京国枫律师事务所 关于山东三元生物科技股份有限公司 2026 年第一次临时股东会的 法律意见书 国枫律股字[2026]A0063 号 致：山东三元生物科技股份有限公司（贵公司） 北京国枫律师事务所（以下简称"本所"）接受贵公司的委托，指派律师出席并见 证贵公司 2026 年第一次临时股东会（以下简称"本次会议"）。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》（以下简称 "《股东会规则》"）、《律师事务所从事证券法律业务管理办法》（以下简称"《证券法律 业务管理办法》"）、《律师事务所证券法律业务执业规则（试行）》（以下简称"《证券法 律业务执业规则》"）等相关法律、行政法规、规章、规范性文件及《山东三元生物科技 股份有限公司章程》（以下简称"《公司章程》"）的规定，就本次会议的召集与召开程 序、召集人资格、出席会议人员资格、会议表决程序及表决结果等事宜 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东会未出现否决议案的情形。 证券代码：301206 证券简称：三元生物 公告编号：2026-011 山东三元生物科技股份有限公司 2026 年第一次临时股东会决议公告 5、会议主持人：董事长聂在建 6、会议召开情况的合法、合规性说明：本次会议的召集、召开与表决程序 符合《公司法》《深圳证券交易所创业板股票上市规则》及《公司章程》的有关 规定，所作决议合法有效。 2、本次股东会未涉及变更以往股东会已通过的决议。 一、会议召开和出席情况 （一）会议召开情况 1、会议召开时间： 现场会议时间：2026 年 2 月 24 日（星期二）15:00 网络投票时间：通过深圳证券交易所交易系统进行网络投票的具体时间为： 2026 年 2 月 24 日 9:15—9:25，9:30—11:30 和 13:00—15:00；通过深圳证券交易 所互联网投票系统的具体时间为：2026 年 2 月 24 日 9:15 至 15:00 2、会议召开地点：山东省滨州市滨北梧桐十路 101 号三元生物公司会议室 3、会议召 ...

公司年产2万吨阿洛酮糖项目中剩余1万吨产能已完成工程主体建设和设备安装，后续将组织环评验收， 并分阶段推进投产。该项目旨在丰富产品体系，但投产进度和效益受验收程序、市场需求等因素影响。 业务进展情况 莱鲍迪苷M正持续向国内外意向客户提供样品并开展应用实验，部分客户已将其用于减糖产品配方升 级；塔格糖作为重点新型功能糖，处于市场推广与产业化应用的关键阶段。 经济观察网 三元生物（301206）（301206）近期面临美国反倾销终裁生效、阿洛酮糖项目推进及新产 品推广等多重动态。 股票近期走势 美国商务部公布了对中国赤藓糖醇产品反倾销和反补贴调查的终裁结果，三元生物出口美国的综合执行 税率为93.58%。该结果自美国《联邦公报》正式刊登之日起生效，可能对公司美国市场业务产生持续 影响。此外，欧盟自2025年1月起对中国赤藓糖醇征收156.7%的反倾销税（实施期5年），公司已通过 推出复配产品等措施应对，该事件的影响可能持续。 公司项目推进 公司状况 公司于2026年2月4日召开董事会会议，审议了关于召开2026年第一次临时股东会的议案，相关安排待进 一步公告。 ...

Core Viewpoint - San Yuan Bio announced that as of February 10, 2026, the company has a total of 15,658 registered shareholders [2] Company Summary - The company is actively engaging with investors through interactive platforms, indicating a focus on transparency and communication [2] - The number of registered shareholders reflects the company's growth and potential interest from the investment community [2]

Group 1 - The core viewpoint of the article highlights that the domestic ex-factory price of erythritol in the United States is considered non-public commercial information and is typically higher than that of Chinese export products due to local energy, labor, and raw material costs [1] - The company will continue to monitor global price trends and aims to maintain its core competitiveness through technological innovation and cost optimization in response to changes in the international trade environment [1]

Group 1 - The company is actively providing samples of Reb M to domestic and international potential clients, with some clients already incorporating it into their sugar-reduction product formulations [2] - Tagatose, as a key focus for the company, is currently in a critical phase of market promotion and industrial application, with steady progress being made [2] - The company has utilized Reb M in the formulation of products containing erythritol and allulose, enhancing product quality and market competitiveness [2]

Core Viewpoint - The final ruling on anti-dumping and countervailing duties ("double anti") against Chinese erythritol products has been announced, with the leading company, Sanyuan Biotech, facing a maximum combined tax rate of 93.58%, significantly impacting its market competitiveness in the U.S. [1][2] Group 1: Tax Rates and Impact - Sanyuan Biotech has been assigned a countervailing duty rate of 8.63% and an anti-dumping duty rate of 84.95%, leading to a total tax rate of 93.58% [1][2] - The company did not qualify for separate rate status, resulting in a unified tax rate of 184.26% for other exporters, although this is a reduction from the initial rate of 450.64% [2] - The high tax rates are expected to diminish Sanyuan's cost competitiveness in the U.S. market, leading to potential order reductions and market share loss [2][3] Group 2: Market Dynamics and Alternatives - The U.S. market for sweeteners is significant, with 30%-40% of beverages being imported, indicating ongoing demand despite the tariff challenges [3] - Sanyuan Biotech can explore alternative market strategies, such as changing product forms to bypass tariffs or utilizing third-party channels for U.S. market entry [4] - The company is also developing alternatives to erythritol, such as allulose, which is projected to be a strategic sweetener with lower calories and a taste profile similar to sucrose [5] Group 3: Future Prospects and Innovations - Sanyuan Biotech is focusing on technological innovation to extend its product offerings beyond traditional sugar alcohols, which are already cost-effective due to mature production processes [5] - The company aims to tap into emerging markets in Southeast Asia, India, the Middle East, and South America as part of its growth strategy [4][5]

Core Viewpoint - The final ruling on anti-dumping and countervailing duties ("double reverse") against Chinese erythritol products has been announced, with Tsinghua Biotech facing a maximum combined tax rate of 93.58%, significantly impacting its market competitiveness in the U.S. [2][3] Group 1: Tax Rates and Impact - Tsinghua Biotech's final anti-subsidy rate is 8.63%, and the anti-dumping rate is 84.95%, leading to a total tax rate of 93.58% [2][3] - The company did not qualify for separate rate status, resulting in a nationwide unified tax rate of 184.26% for other producers/exporters without separate rate qualifications [3] - The high tax rates are expected to weaken Tsinghua Biotech's cost competitiveness in the U.S. market, leading to potential order reductions and market share loss [3] Group 2: Market Demand and Supply Dynamics - The U.S. is projected to have a per capita sugar and sweetener consumption of approximately 121 pounds (about 55 kg) in 2025, with erythritol being a popular choice due to its natural and zero-calorie properties [5] - Global demand for erythritol is expected to reach 238,000 tons in 2024, with a compound annual growth rate (CAGR) of 22% from 2020 to 2024, indicating strong market demand [5] - The global erythritol market is forecasted to reach $2.63 billion by 2030, with a growth rate of 21.0% during the 2024-2030 period [5] Group 3: Industry Competition and Challenges - The introduction of new production capacities in 2022 has led to an imbalance in the erythritol market, resulting in increased competition and a risk of low-quality products displacing higher-quality ones [6] - Analysts note that erythritol is not a high-barrier product, and ongoing innovations may highlight its limitations [7] Group 4: Strategic Alternatives - Tsinghua Biotech can potentially circumvent the high tariffs by altering product forms, such as selling processed erythritol products directly to consumers [8] - The company is exploring third-party channels and overseas production to maintain market access in the U.S. [8] - Tsinghua Biotech is also developing alternatives like allulose, which is gaining global recognition and is expected to expand its market significantly [9]

Industry News - The Ministry of Transport's new regulatory meeting addressed issues with Gaode Taxi, highlighting management shortcomings and requiring immediate corrective actions to protect driver rights [41] - The Ministry of Commerce held a meeting with automotive companies to discuss strategies for enhancing automotive consumption, including the implementation of a vehicle trade-in program and industry management improvements by 2026 [41] - Apple plans to launch a new iPhone Flip model following the iPhone Fold, prompting Samsung Display to evaluate expanding OLED panel production capacity for Apple [41] - Rare earth product prices have increased, with praseodymium-neodymium oxide averaging 798,800 yuan/ton, up 41,300 yuan/ton; neodymium metal averaging 976,300 yuan/ton, up 61,900 yuan/ton; dysprosium oxide averaging 1,400,800 yuan/ton, up 16,500 yuan/ton; and terbium oxide averaging 6,214,300 yuan/ton, up 77,200 yuan/ton [41][42] Company News - Zhiguang Electric announced a contract for the sale of energy storage systems worth 1.004 billion yuan [43] - Zhejiang Longsheng reported a price increase of 5,000 yuan/ton for certain disperse dyes as of February 8 [43] - Source Technology plans to invest 1.251 billion yuan in the second phase of its optical communication semiconductor chip and device R&D production base [48] - Jinwei Co. intends to acquire 100% of Fusheng Mining for 210 million yuan, with the target company holding mining rights for a production scale of 50,000 tons/year [48]